Neurometrix Inc
(NURO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,806 | -6,026 | -4,518 | -3,030 | -6,530 |
| Depreciation Amortization | 233 | 177 | 117 | 25 | 41 |
| Accounts receivable | 326 | 370 | 238 | 49 | 128 |
| Accounts payable and accrued liabilities | 148 | 132 | 99 | -71 | -153 |
| Other Working Capital | 570 | 699 | 1,021 | 838 | 6 |
| Other Operating Activity | -599 | -590 | -403 | 107 | 423 |
| Operating Cash Flow | $-7,128 | $-5,238 | $-3,446 | $-2,081 | $-6,085 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,348 | 2,954 | 1,847 | 138 | 1,340 |
| PPE Investments | N/A | N/A | N/A | N/A | -184 |
| Investing Cash Flow | $5,348 | $2,954 | $1,847 | $138 | $1,156 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,476 | 1,474 | 1,474 | 1,471 | 2,325 |
| Financing Cash Flow | $1,476 | $1,474 | $1,474 | $1,471 | $2,325 |
| Beginning Cash Position | 1,732 | 1,732 | 1,732 | 1,732 | 4,335 |
| End Cash Position | 1,428 | 922 | 1,607 | 1,260 | 1,732 |
| Net Cash Flow | $-304 | $-810 | $-125 | $-472 | $-2,603 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,128 | -5,238 | -3,446 | -2,081 | -6,085 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -184 |
| Free Cash Flow | -7,128 | -5,238 | -3,446 | -2,081 | -6,268 |